Hormone replacement therapy in menopause at Polyclinic Cito includes an individualized and safe plan (HRT).
It can be very effective in relieving menopausal symptoms such as hot flashes, night sweats, insomnia, mood changes and urogenital complaints. However, HRT is not “for everyone” - the decision is made individually after an assessment of symptoms, overall health and risks. At Polyclinic Cito we perform an expert assessment, an ultrasound and targeted tests when needed, and build a safe therapy and monitoring plan.
Hormone replacement therapy in menopause involves the use of hormones (most often oestrogen, with the addition of a progestogen in women who have a uterus) to replace the hormones the body has stopped producing and thereby ease the symptoms and, in selected cases, gain additional benefits (e.g. the preservation of bone mass in women at higher risk).
Note: HRT is most often considered when symptoms caused by menopause significantly impair quality of life, and a safety assessment shows that the therapy is appropriate.
The most common situations in which it can significantly ease menopausal symptoms - provided that the therapy is a safe choice for the individual patient.
The intensity, triggers, sleep, urogenital complaints and expectations are assessed.
The state of the vagina and mucosa and the general gynaecological status are assessed to determine whether there is a need for further work-up before therapy.
Ultrasound of the uterus and ovaries and targeted laboratory tests when there are symptoms such as bleeding or other risk factors.
The form of therapy is chosen (tablets, a patch, gel, local), the dose is determined, and a plan of follow-up examinations is agreed.
Note your personal and family history (thrombosis, cancers, heart disease).
To make an informed decision, it is important to receive clear information about the benefits, possible risks and the treatment plan.
HRT has the best effect when the therapy is individually chosen, safe and accompanied by a clear monitoring plan. Our expert team provides you with:
Arrange a consultation – you will receive a clear assessment of the benefits and risks and a plan that suits your symptoms.
The price at Cito Polyclinic is 40 €. Please bear in mind that additional diagnostic tests, such as a Pap test and an ultrasound examination, are not included in this price and are charged separately according to the current price list.
You can get the first available appointment straight away by phone on +385 21 457 800 or by sending a short message via the contact form.
Specialist in Gynecology and Obstetrics
Subspecialist in Gynecological Endocrinology and Human Reproduction
Specialist in Gynecology and Obstetrics
Subspecialist in Gynecological Endocrinology and Human Reproduction
Specialist in Gynecology and Obstetrics
Subspecialist in Gynecological Endocrinology and Human Reproduction
Specialist in Gynecology and Obstetrics
Specialist in Gynecology and Obstetrics
Find answers to common questions about this service
It is recommended for women with moderate to severe vasomotor symptoms and urogenital atrophy. Benefits include symptom relief and bone protection; risks depend on age, duration and regimen.
Systemic estrogen with progestin in women with a uterus, estrogen alone after hysterectomy; forms are oral, transdermal, gels and the LNG-IUD for endometrial protection.
Check-ups are at 3–6 months after initiation, then annually, with assessment of symptoms, blood pressure, breasts and risks.
Breast tenderness, bleeding and fluid retention are possible; therapy is adjusted for side effects or changes in the risk–benefit profile.
